FDA Proposes Changes to Biologics Regulations to Remove Outdated Requirements and Improve Flexibility

Summary

The Food and Drug Administration (FDA) is proposing to amend its biologics regulations to remove outdated inspection requirements and inspector duties, aiming to provide flexibility without compromising public health protections, as part of its efforts to implement Executive Orders 13771 and 13777.